These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Type 1 interferon signature in peripheral blood mononuclear cells and monocytes of idiopathic inflammatory myopathy patients with different myositis-specific autoantibodies. Li M; Zhang Y; Zhang W; Sun J; Liu R; Pan Z; Zhang P; Liu S Front Immunol; 2023; 14():1169057. PubMed ID: 37228600 [TBL] [Abstract][Full Text] [Related]
3. Ro52/TRIM21-deficient expression and function in different subsets of peripheral blood mononuclear cells is associated with a proinflammatory cytokine response in patients with idiopathic inflammatory myopathies. Gómez-Martín D; Galindo-Feria AS; Barrera-Vargas A; Merayo-Chalico J; Juárez-Vega G; Torres-Ruiz J; Alcocer-Varela J Clin Exp Immunol; 2017 Apr; 188(1):154-162. PubMed ID: 27936488 [TBL] [Abstract][Full Text] [Related]
4. Using peripheral blood immune signatures to stratify patients with adult and juvenile inflammatory myopathies. Wilkinson MGL; Radziszewska A; Wincup C; Ioannou Y; Isenberg DA; Manson JJ; Jury EC Rheumatology (Oxford); 2020 Jan; 59(1):194-204. PubMed ID: 31292651 [TBL] [Abstract][Full Text] [Related]
5. Lymphocyte immunophenotyping in inflammatory myositis: a review. Franco C; Gatto M; Iaccarino L; Ghirardello A; Doria A Curr Opin Rheumatol; 2021 Nov; 33(6):522-528. PubMed ID: 34402455 [TBL] [Abstract][Full Text] [Related]
6. TLR expression in peripheral monocyte subsets of patients with idiopathic inflammatory myopathies: association with clinical and immunological features. Torres-Ruiz J; Carrillo-Vazquez DA; Padilla-Ortiz DM; Vazquez-Rodriguez R; Nuñez-Alvarez C; Juarez-Vega G; Gomez-Martin D J Transl Med; 2020 Mar; 18(1):125. PubMed ID: 32164729 [TBL] [Abstract][Full Text] [Related]
7. Proinflammatory Histidyl-Transfer RNA Synthetase-Specific CD4+ T Cells in the Blood and Lungs of Patients With Idiopathic Inflammatory Myopathies. Galindo-Feria AS; Albrecht I; Fernandes-Cerqueira C; Notarnicola A; James EA; Herrath J; Dastmalchi M; Sandalova T; Rönnblom L; Jakobsson PJ; Fathi M; Achour A; Grunewald J; Malmström V; Lundberg IE Arthritis Rheumatol; 2020 Jan; 72(1):179-191. PubMed ID: 31403245 [TBL] [Abstract][Full Text] [Related]
8. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Troyanov Y; Targoff IN; Tremblay JL; Goulet JR; Raymond Y; Senécal JL Medicine (Baltimore); 2005 Jul; 84(4):231-249. PubMed ID: 16010208 [TBL] [Abstract][Full Text] [Related]
9. Quantitative T cell subsets profile in peripheral blood from patients with idiopathic inflammatory myopathies: tilting the balance towards proinflammatory and pro-apoptotic subsets. Espinosa-Ortega F; Gómez-Martin D; Santana-De Anda K; Romo-Tena J; Villaseñor-Ovies P; Alcocer-Varela J Clin Exp Immunol; 2015 Mar; 179(3):520-8. PubMed ID: 25348796 [TBL] [Abstract][Full Text] [Related]
10. [Classification of idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific antibodies]. Zheng S; Chen S; Wu L; Zhao D; Chen F; Zhu J; Li J Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):1029-1035. PubMed ID: 32895158 [TBL] [Abstract][Full Text] [Related]
11. Peripheral Blood Lymphocyte Subsets and Heterogeneity of B Cell Subsets in Patients of Idiopathic Inflammatory Myositis with Different Myositis-specific Autoantibodies. Pan Z; Li M; Zhang P; Li T; Liu R; Liu J; Liu S; Zhang Y Inflammation; 2024 May; ():. PubMed ID: 38755405 [TBL] [Abstract][Full Text] [Related]
13. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies. Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809 [TBL] [Abstract][Full Text] [Related]
14. Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies: study of 178 cases and guidelines for diagnosis. Fernandez C; Bardin N; De Paula AM; Salort-Campana E; Benyamine A; Franques J; Schleinitz N; Weiller PJ; Pouget J; Pellissier JF; Figarella-Branger D Medicine (Baltimore); 2013 Jan; 92(1):15-24. PubMed ID: 23269233 [TBL] [Abstract][Full Text] [Related]
15. The spectrum of idiopathic inflammatory myopathies in South Africa. Chinniah KJ; Mody GM Clin Rheumatol; 2021 Apr; 40(4):1437-1446. PubMed ID: 32212001 [TBL] [Abstract][Full Text] [Related]
16. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre. Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients. Chung SW; Yoo IS; Kim J; Kang SW; Kwon M; Joung CI; Choi IA; Chang SH; Kang MI; Hong SJ; Lee YA Yonsei Med J; 2021 May; 62(5):424-430. PubMed ID: 33908213 [TBL] [Abstract][Full Text] [Related]
20. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Ichimura Y; Matsushita T; Hamaguchi Y; Kaji K; Hasegawa M; Tanino Y; Inokoshi Y; Kawai K; Kanekura T; Habuchi M; Igarashi A; Sogame R; Hashimoto T; Koga T; Nishino A; Ishiguro N; Sugimoto N; Aoki R; Ando N; Abe T; Kanda T; Kuwana M; Takehara K; Fujimoto M Ann Rheum Dis; 2012 May; 71(5):710-3. PubMed ID: 22258483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]